SynthesisBMC infectious diseases2025
The prevalence of adverse drug reactions to antiretroviral therapy and associated factors among pediatric patients living with HIV in sub-Saharan African countries: a systematic review and meta-analysis.
Synthesis in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Preparation, Oral SNEDDS Formulation, and In Vivo Evaluation of the HIV-1 Latency-Reversing Agent EK-16A.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe greatest burden of HIV infection is in sub-Saharan African countries. The burden of treatment failure among children living with HIV remains significantly high due to delayed diagnosis and antiretroviral therapy (ART) initiation, low ART adherence rate, virological non-suppression, and incidence of adverse drug reactions (ADRs) to ART, among other factors. Therefore, this systematic review aims to estimate the pooled prevalence of ADRs among HIV-positive pediatric patients on ART in sub-Saharan Africa, identify the types, and examine associated risk factors as documented in the literature.
methodsThis review is based on a systematic and extensive search of PubMed, Scopus, CINAHL, Web of Science, and EBSCOHost. Data were extracted from the included studies using the data extraction form designed by the team. A meta-analysis was done using R statistics, version 4.3.2.
resultsA total of nine articles were included. The pooled estimate of ADRs among children on ART was statistically significant 26% (95% CI 0.15, 0.36; P-value < 0.001) with high heterogeneity. The types of ADRs reported in the included studies are gastrointestinal, dermatological, central nervous system, hematological, liver pathology, metabolic disorder, cardiovascular, and hormonal imbalance symptoms. Some of the factors associated with the occurrence of ADRs include treatment duration, the combination of ART used, sex, age, malnutrition, and compliance. The pooled prevalence of mortality among children on ART was statistically significant, with high heterogeneity.
conclusionThe review highlighted the prevalence and factors associated with ADRs in HIV-positive children on ART in the SSA countries. As the SSA countries battle to achieve the UNAIDS 95-95-95 targets in this vulnerable population, preliminary insights from this review can help inform policies on integrating spontaneous reporting of ADRs and pharmacovigilance into the service delivery component of pediatric ART. This intervention will support patient retention in care, as ADRs are a significant cause of medication non-adherence. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.